BRCA1, PARP1 and γH2AX in acute myeloid leukemia: Role as biomarkers of response to the PARP inhibitor olaparibIsabella Faraoni, Francesco Lo‐Coco|Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease|2014Cited by 62
Vitamin C Deficiency in Patients With Acute Myeloid LeukemiaTiziana Ottone, Maria Teresa Voso, Isabella Faraoni et al.|Frontiers in Oncology|2022Cited by 18
Poly(ADP-Ribose) Polymerase Inhibitors for Arsenic Trioxide–Resistant Acute Promyelocytic Leukemia: Synergistic In Vitro Antitumor Effects with Hypomethylating Agents or High-Dose Vitamin CManuela Giansanti, Isabella Faraoni|Journal of Pharmacology and Experimental Therapeutics|2021Cited by 10
Polydatin-Induced Shift of Redox Balance and Its Anti-Cancer Impact on Human Osteosarcoma CellsChiara Ciaccio, Isabella Faraoni, Stefano Marini et al.|Current Issues in Molecular Biology|2024Cited by 4